The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2026 And What Value Is Projected For 2030?
The topical drugs contract development and manufacturing organization (cdmo) market has seen rapid expansion in recent years. Its size is anticipated to grow from $61.16 billion in 2025 to $70.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. The market’s past growth is attributable to an increase in pharmaceutical outsourcing, the rising prevalence of dermatological conditions, pharmaceutical companies’ focus on cost optimization, escalating regulatory complexity, and the expansion of generic topical drugs.
The topical drugs contract development and manufacturing organization (CDMO) market size anticipates significant expansion over the coming years. Projections indicate it will reach $121.22 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.3%. This projected growth during the forecast period is fueled by factors such as the accelerated development of sophisticated topical treatments, a heightened demand for transdermal patches, the broadening pipelines of small and mid-sized pharmaceutical companies, an escalating requirement for scalable production capabilities, and an intensified emphasis on reducing time to market. Key trends anticipated during this period encompass a surge in outsourcing for topical drug production, an increasing appetite for intricate topical formulations, the broadening of transdermal drug delivery platforms, a heightened emphasis on manufacturing in adherence to regulatory standards, and an elevated need for comprehensive, end-to-end CDMO solutions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15942&type=smp
What Major Drivers Are Influencing Demand In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
The future expansion of the topical drugs contract development and manufacturing organization (CDMO) market is anticipated to be driven by the growing incidence of skin diseases. These are medical conditions impacting the skin, manifesting with symptoms like inflammation, itching, and lesions. This rise in prevalence is linked to factors such as environmental pollution, exposure to UV radiation, genetic susceptibility, shifts in lifestyle, and microbial infections. By developing and manufacturing specialized therapies that enhance the management and treatment of dermatological conditions, the topical drugs contract development and manufacturing organization (CDMO) aids in reducing the occurrence of skin diseases. As an illustration, in 2023, Cancer Australia, an Australia-based government agency, reported approximately 8,257 new cases of melanoma of the skin, which constituted 2.6% of all deaths from cancer. This demonstrates how the rising prevalence of skin diseases is stimulating the growth of the topical drugs contract development and manufacturing organization (CDMO) market.
What Are The Key Segments Of The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
The topical drugs contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders
4) By Transdermal Products: Patches
What Key Trends Are Influencing The Development Of The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Leading firms within the topical drugs contract development and manufacturing organization (CDMO) market are prioritizing the establishment of cutting-edge manufacturing facilities to maintain their competitive standing. Such advanced facilities represent dedicated production sites featuring the newest technology and sophisticated processes specifically designed for the creation and production of topical pharmaceutical goods. As an example, in November 2023, SOHM Inc., a US-based pharmaceutical company, inaugurated a CDMO GMP manufacturing facility. This new Carlsbad facility is designed to provide substantial space for both the production of topical products and SOHM’s overall operations, including 2,500 square feet allocated for the storage of completed goods. Initially, its daily production capability for topicals will be 500 gallons (1,892 liters). The facility anticipates expanding its capacity to incorporate soft-gel suppositories by the close of Q1 2024 or the beginning of Q2 2024.
Who Are The Leading Companies Operating In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the topical drugs contract development and manufacturing organization (cdmo) market are Catalent Inc., Lonza Group AG, Recipharm AB, Piramal Pharma Solutions, Cambrex Corporation, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., MedPharm Ltd, Tergus Pharma LLC, NextPharma Technologies Holding Limited, Bora Pharmaceuticals Co. Ltd., LTS Lohmann Therapie-Systeme AG, CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., Dow Development Laboratories LLC, Tedor Pharma Inc.
Read the full topical drugs contract development and manufacturing organization (cdmo) market report here:
Which Region Shows The Strongest Potential For Future Growth In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the topical drugs contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15942&type=smp
Browse Through More Reports Similar to the Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model